MORETTI, GABRIELLA
 Distribuzione geografica
Continente #
NA - Nord America 228
EU - Europa 45
AS - Asia 24
Totale 297
Nazione #
US - Stati Uniti d'America 228
IT - Italia 16
CN - Cina 11
SG - Singapore 11
DE - Germania 6
GB - Regno Unito 6
RU - Federazione Russa 5
BE - Belgio 2
FI - Finlandia 2
FR - Francia 2
IE - Irlanda 2
IN - India 2
ES - Italia 1
RO - Romania 1
SE - Svezia 1
UA - Ucraina 1
Totale 297
Città #
Fairfield 44
Chandler 29
Ashburn 19
Ann Arbor 18
Wilmington 17
Woodbridge 15
Cambridge 13
Seattle 13
Houston 12
Singapore 8
Des Moines 6
Medford 6
Altamura 4
London 4
San Diego 4
Dearborn 3
Lawrence 3
Nanjing 3
Princeton 3
Boardman 2
Brussels 2
Dublin 2
Frankfurt am Main 2
Helsinki 2
Palermo 2
San Paolo di Civitate 2
Venice 2
Bari 1
Beijing 1
Berlin 1
Changsha 1
Columbus 1
Gradisca D'isonzo 1
Hangzhou 1
Hebei 1
Kumar 1
Ludwigshafen am Rhein 1
Ningbo 1
Orange 1
Pamplona 1
Pune 1
Saint Petersburg 1
Shenyang 1
Totale 256
Nome #
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 123
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study 102
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial 91
Totale 316
Categoria #
all - tutte 1.595
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.595


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202047 0 0 0 0 7 11 8 7 7 3 3 1
2020/202186 2 3 0 3 37 5 0 6 5 12 9 4
2021/202238 2 11 0 1 1 1 3 1 3 5 3 7
2022/202368 6 16 1 7 5 14 4 4 8 0 2 1
2023/202424 1 5 5 3 0 2 2 0 0 0 1 5
2024/20258 0 2 0 5 1 0 0 0 0 0 0 0
Totale 316